ExoFem™ — EV care for preconception and menopause stages
ExoFem™ is TONGNIAN's women's line: gentle intimate-care mists and stage-specific oral pairings, built for brands serving preconception and menopause-stage programs with soft-care positioning. Consumer retail formats lead; professional clinic formats follow as programs mature. The line runs on the shared fully enclosed micro-batch platform with batch COAs on every shipment.
Who this line serves
- women on fertility journeys (30–42) — gentle daily-ritual pairings within preconception wellness programs.
- menopausal routines (45–55) — stage-specific comfort formats within 45+ women's programs.
- Women's health retailers — documented, sensitive-category formats a retailer can put on shelf without claim risk.
Line programs
| Program | Population | Dosage form | Status |
|---|---|---|---|
| Intimate-care gentle mist | Preconception · menopause stages | Rose-EV gentle mist, 80 mL (sample) | Pilot-ready |
| Preconception-stage oral pairing | Preconception stage | Oral liquid via the OralBio™ base | Cross-line program |
| Menopause-stage oral pairing | Menopause stage | Daily softgel via the OralBio™ base | Cross-line program |
| Clinic professional formats | Professional use | Clinic-track products (program design stage) | Follows C-end maturity |
What the line is designed to do
- Soft-care discipline — mild formulas and restrained wording for intimate care and the preconception-to-menopause stages, where a single overclaim can cost the listing.
- Stage-specific pairing — topical comfort formats paired with the OralBio™ oral base per life stage.
- C-end first, clinic behind — retail formats establish the category; professional formats follow with program support.
- Documented batches — batch COA and characterization summary with every shipment.
Specs & characterization
| Item | Value |
|---|---|
| EV system | Rose-derived plant EV fractions + characterized EV base (sample) |
| Vesicle size (NTA) | 80–200 nm range by format (sample) |
| Formats | 80 mL gentle mist; oral pairings via OralBio™ base (sample) |
| QC panel | NTA, TEM, endotoxin (LAL), microbial limits; batch COA |
| Storage | Cool, light-protected (sample) |
| Compliance status | EV material line: FDA DMF Type II 044197 · INCI 41316; finished goods on cosmetic / filing-appropriate tracks |
| Typical program | Pilot from 500 units · production from 2,000 units · standard lead 15 workdays |
Quality & compliance
- Sensitive-category guardrails — intimate-care products stay on strict cosmetic wording; no health claims.
- Material chain — DMF Type II 044197 and INCI 41316 on the EV material line; batch COAs with every shipment.
- Closed line — production on the fully enclosed 0.5–5 L micro-batch platform.
- Program sequencing — oral pairings launch on the destination market's filing route; clinic formats follow once consumer retail is established.
Work with this line: start via Request a quote, or review the OBM program for women's-program bundles.
Request a quote
Customize ExoFem™ dosage forms and skin feel for your brand.
Share your brand stage and target category, and we’ll return sample specs, an MOQ framework, and characterization samples (typical: sample kits in 3–5 days); to review the full-line design first, head to Knowledge · Solutions.